FDA’s abrupt flip-flop on Moderna’s mRNA flu shot highlights growing risks to drug-makers of investing in vaccines
- Written by Ana Santos Rutschman, Professor of Law, Villanova University
Federal health officials have raised safety concerns about mRNA vaccines, although they have provided no credible data on health risks.NurPhoto via Getty ImagesThe Food and Drug Administration’s decision, made public on Feb. 10, 2026, to not review an application to approve Moderna’s proposed mRNA-based flu vaccine set off a firestorm...









